WallStSmart
MBIO

Mustang Bio Inc

NASDAQ: MBIO · HEALTHCARE · BIOTECHNOLOGY

$0.75
-0.66% today

Updated 2026-04-29

Market cap
$5.68M
P/E ratio
P/S ratio
2,205.73x
EPS (TTM)
$-0.39
Dividend yield
52W range
$1 – $4
Volume
0.0M

Mustang Bio Inc (MBIO) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20152016201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$0.00$0.00$2000.00$630000.00$1.37M$1.78M$2.31M$3.03M$2.23M$823000.00$41000.00
Gross profit$0.00$0.00$-2000.00$-630000.00$-1.37M$-1.78M$-2.31M$-3.03M$-2.23M$-823000.00$-41000.00
Gross margin
R&D$4.04M$8.55M$20.38M$24.46M$36.31M$45.62M$53.54M$63.95M$39.18M$8.42M$1.52M
SG&A$304800.00$2.82M$11.41M$6.76M$9.57M$9.51M$11.02M$12.21M$9.69M$4.13M$3.95M
Operating income$-4.30M$11.36M$-31.79M$-31.22M$-45.88M$-56.81M$-66.72M$-76.16M$-50.73M$-16.25M$-2.43M
Operating margin
EBITDA$-4.30M$-11.35M$-31.28M$-30.02M$-43.25M$-54.31M$-64.05M$-71.14M$-48.06M$-14.92M$-2.39M
EBITDA margin
EBIT$-5.16M$11.36M$-31.28M$-30.65M$-44.62M$-56.10M$-66.36M$-74.17M$-50.29M$-15.75M$-2.43M
Interest expense$168000.00$1.15M$8000.00$8000.00$1.77M$3.92M$15000.00$3.36M$1.31M$5000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-4.47M$-12.65M$-31.29M$-30.66M$-48.16M$-60.02M$-66.37M$-77.53M$-51.60M$-15.75M$-1.92M
Net income growth (YoY)-183.3%-147.3%+2.0%-57.1%-24.6%-10.6%-16.8%+33.4%+69.5%+87.8%
Profit margin